Notification That Form 20-f Will Be Submitted Late (nt 20-f)
August 10 2020 - 11:04AM
Edgar (US Regulatory)
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
|
OMB APPROVAL
|
|
|
OMB Number:
|
3235-0058
|
|
|
Expires:
|
February 28, 2022
|
|
|
Estimated average burden
Hours per form
|
2.50
|
|
|
SEC FILE NUMBER
001-35681
|
|
|
CUSIP NUMBER
G0335L 102
|
|
(Check One):
|
o Form 10-K
|
☒ Form 20-F
|
o Form 11-K
|
o Form 10-Q
|
o Form 10-D
|
o Form N-SAR
|
o Form N-CSR
|
|
|
|
|
|
|
|
|
|
|
|
For Period Ended: March 31, 2020
|
|
|
|
|
|
o Transition Report on Form 10-K
|
|
|
o Transition Report on Form 20-F
|
|
|
o Transition Report on Form 11-K
|
|
|
o Transition Report on Form 10-Q
|
|
|
o Transition Report on Form N-SAR
|
|
|
|
|
|
For the Transition Period Ended: ____________________
|
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A
PART I - REGISTRANT INFORMATION
|
Amira Nature Foods Ltd
|
|
Full Name of Registrant
|
|
|
|
N/A
|
|
Former Name if Applicable
|
|
|
|
29E, A.U. Tower, Jumeirah Lake Towers
|
|
Address of Principal Executive Office (Street and Number)
|
|
|
|
Dubai, United Arab Emirates
|
|
City, State, Zip Code
|
PART II - RULES 12b-25 (b) AND (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
|
|
(a)
|
The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
|
|
|
|
|
|
☒
|
(b)
|
The Company will use its best efforts to file the subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
|
|
|
|
|
|
|
(c)
|
The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART III - NARRATIVE
State below in reasonable detail the reasons why the Form 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof could not be filed within the prescribed time period. (Attach extra sheets if needed).
The Company’s Annual Report on Form 20-F for the year ended March 31, 2020 was unable to be completed in time without unreasonable effort and expense to the Company because of the COVID-19 pandemic and the corporate organization restructuring that occurred as a result of the de-consolidation of the Indian subsidiary as of November 18, 2018.
PART IV - OTHER INFORMATION
|
(1)
|
Name and telephone number of person to contact in regard to this notification:
|
|
Brian M. Speck
|
|
+971
|
|
44357303
|
|
(Name)
|
|
(Area Code)
|
|
(Telephone No.)
|
|
(2)
|
Have all other periodic reports required under section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s). o Yes ☒ No
|
|
|
|
|
|
Form 6-K for period ending September 30, 2019
Form 20-F for year ended March 31, 2019
|
|
|
|
|
(3)
|
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? o Yes ☒ No
|
|
|
|
|
|
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
|
AMIRA NATURE FOODS LTD
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
Date: August 10, 2020
|
By:
|
/s/ Brian M. Speck
|
|
|
|
|
Brian M. Speck,
|
|
|
|
|
Chief Financial Officer
|
|
INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.
Amira Nature Foods (NYSE:RYCE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amira Nature Foods (NYSE:RYCE)
Historical Stock Chart
From Apr 2023 to Apr 2024
